Peris I, Romero-Murillo S, Martinez-Balsalobre E, Farrington CC, et al. Activation of the PP2A-B56alpha heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood 2023;141:1047-1059.
PMID: 36455198